Doxycycline (SKU BA1003): Reliable Solutions for Cell Assays
2026-06-06
This article addresses practical laboratory challenges in cell viability, proliferation, and cytotoxicity assays by demonstrating how APExBIO’s Doxycycline (SKU BA1003) enables reproducible, data-driven experiments. Integrating scenario-based Q&A and the latest mechanistic insights, it guides biomedical researchers and lab technicians in optimizing protocols and interpreting results with scientific rigor.
Annexin V, Human Recombinant: Precision in Immune Cell Apopt
2026-06-05
Discover how Annexin V, a leading phosphatidylserine binding protein, empowers advanced apoptosis assays and immune cell research. This article uniquely bridges mechanistic insight with the latest immunological findings, offering researchers practical protocols and critical perspectives.
Trypsin-Responsive Mesoporous Nanomedicine for Acute Pancrea
2026-06-05
This study presents a biomimetic, trypsin-sensitive mesoporous organosilica nanomedicine for acute pancreatitis treatment. By engineering trypsin-cleavable linkers and targeted delivery mechanisms, the researchers achieve precise drug release in injured pancreatic acinar cells, markedly improving therapeutic outcomes in preclinical models.
Panobinostat Disrupts H2B Ubiquitination in MLL-ALL Therapy
2026-06-04
This study demonstrates that panobinostat, a broad-spectrum HDAC inhibitor, exerts potent in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia by targeting the RNF20/RNF40/WAC-H2B ubiquitination pathway. The findings reveal a mechanistic link between histone deacetylation and ubiquitination that opens new avenues for therapeutic intervention in aggressive infant ALL.
Live-Dead Cell Staining Kit I: Precision Mammalian Viability
2026-06-04
The Live-Dead Cell Staining Kit I (Calcein AM/PI) enables rapid, dual-probe fluorescence discrimination of live and dead mammalian cells. This kit supports robust cell viability and cytotoxicity quantification, critical for translational research and biomaterial evaluation. APExBIO's validated protocol ensures reproducible results in advanced cell membrane integrity assays.
A40926: Dalbavancin Precursor for Advanced Antibacterial Ass
2026-06-03
A40926, the natural glycopeptide and dalbavancin precursor, empowers high-fidelity research against multidrug-resistant Gram-positive pathogens. Discover how its precise mechanism, robust performance metrics, and tunable workflows set a new benchmark for in vitro and in vivo antibacterial assays.
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Proto
2026-06-03
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents protein degradation during extraction by inhibiting a broad spectrum of proteases without interfering with cation-sensitive downstream applications. It is best suited for workflows requiring intact phosphorylation states, such as Western blotting and co-immunoprecipitation, but should not be used where EDTA-based inhibition is required.
CDK9 Inhibitor (A3294): Technical Use, Protocols, and QC
2026-06-02
CDK9 inhibitor (A3294) provides selective, non-cytotoxic inhibition of cyclin dependent kinase 9, enabling focused studies on transcription elongation and HIV-1 propagation. It should not be used for broad-spectrum CDK inhibition or protocols necessitating long-term storage of working solutions.
Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis
2026-06-02
This study introduces a novel prognostic model for hepatocellular carcinoma (HCC) based on ferroptosis-related genes and identifies atorvastatin as a potential therapeutic agent for inducing ferroptosis in HCC cells. The findings highlight a new pathway for both risk stratification and targeted intervention in liver cancer.
JNJ-26481585 (Quisinostat): Reliable HDAC Inhibition in Canc
2026-06-01
This article explores the practical advantages of JNJ-26481585 (Quisinostat, SKU A4090) for researchers facing cell viability and drug resistance challenges in cancer models. Drawing on recent evidence and validated protocols, it demonstrates how this potent HDAC inhibitor streamlines reproducibility, sensitivity, and workflow reliability for biomedical labs.
PreScission Protease: Optimizing Fusion Protein Tag Cleavage
2026-06-01
PreScission Protease (PSP) enables ultra-specific, low-temperature removal of fusion tags, protecting sensitive recombinant proteins. Its HRV 3C protease mechanism supports advanced workflows in nuclear condensate research and chromatin biology, with robust performance even in challenging applications.
Trelagliptin succinate (A3889): Selective DPP-4 Inhibition i
2026-05-31
Trelagliptin succinate is a long-acting, selective DPP-4 inhibitor used in type 2 diabetes research for its potent glucose-lowering and insulin-sensitizing effects. Its efficacy is supported by modulation of PI3K/Akt/GLUT4 signaling, low cytotoxicity, and consistent in vivo and in vitro benchmarks. APExBIO supplies high-purity Trelagliptin succinate for research applications.
A40926: Translational Leverage for Antibacterial Innovation
2026-05-30
Discover the advanced role of A40926 as a dalbavancin precursor in antibiotic development. This article delivers a translational perspective on optimizing in vitro and in vivo research with A40926, offering practical assay insights and a reference-driven analysis unmatched by existing resources.
Charge-Reversed Exosomes Enable Cartilage-Targeted mRNA Deli
2026-05-29
Zhang et al. introduce charge-reversed, cationic exosomes for the targeted delivery of mRNA into cartilage tissue, overcoming the intrinsic transport barriers of the dense, anionic matrix. This non-viral strategy achieves efficient gene transfer and expression in deep cartilage layers, offering a promising platform for osteoarthritis gene therapy.
Cy5-UTP: Precision RNA Labeling for Advanced Fluorescence As
2026-05-29
Cy5-UTP (Cyanine 5-uridine triphosphate) streamlines high-sensitivity RNA probe synthesis, empowering direct visualization in FISH, dual-color arrays, and single-molecule studies. Its robust fluorescence and proven compatibility with T7 RNA polymerase set a benchmark for reproducibility and multiplexing in RNA labeling workflows.
571 records 17/39 page Previous Next First page 上5页 1617181920 下5页 Last page